Trulieve Cannabis Logo
US89790E1064
A42JFZ

Trulieve Cannabis

Forecast

The analysts' average price target is €13.66 (+68.64%). The median is €13.66 (+68.64%).

Buy
  1
Hold
  0
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Trulieve Cannabis expects quarterly profit and sharp revenue decline

    Trulieve Cannabis is expected to open the books for the quarter ended September 30, 2026, on November 5, 2026. Analysts on average expect earnings of $0.093 per share (prior year: -$0.140) on revenue of $221.9 million, a decline of 23.02% from $288.2 million a year earlier. For the current fiscal year, analysts forecast a mean loss per share of -$1.822 (prior year: -$0.610) and revenue of about $1.01 billion (prior year: $1.18 billion). » More on finanzen.net

Financials

In the last quarter, Trulieve Cannabis had revenue of €203.25M and net profit of €767.2K

(EUR) September 2026
YoY
Revenue 203.25M 17.24%
Gross profit 130.68M 9.71%
Net profit 767.2K 103.36%
EBITDA 52.54M 30.55%

Fundamentals

Metric Value
Market capitalization
€1.55B
Number of shares
170.41M
52-week high/low
€12.09 - €4.20
Dividends No
Beta
1.92
P/E ratio
-4.35
PEG ratio
0.05
P/B ratio
2.50
P/S ratio
1.58

Company profile

Name
Trulieve Cannabis
CEO
Kimberly A. Rivers
Employees 5,000
🍪

Parqet  uses cookies. Learn more